Marcee Wilder

Marcee Wilder

Auto-generated profile, based on publicly available information

Marcee Wilder

Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2021 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
MWMarcee E. Wilder
Marcee E. Wilder
PKPaige Kulie
Paige Kulie
CJCaroline Jensen
Caroline Jensen
PLPaul Levett
Paul Levett
JBJanice Blanchard
Janice Blanchard
MMMelissa L. McCarthy
Melissa L. McCarthy

31 January 2022 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
PDF file
MWMarcee E. Wilder
Marcee E. Wilder
ZZZhanonian Zheng
Zhanonian Zheng
SZScott L. Zeger
Scott L. Zeger
AEAngelo Elmi
Angelo Elmi
RKRichard J. Katz
Richard J. Katz
MMMelissa L. Mccarthy
Melissa L. Mccarthy
Background: Little is known about the relationship between social determinants of health (SDH) and medication adherence among Medicaid beneficiaries with hypertension. Methods: We conducted a posthoc subgroup analysis of 3044 adult Medicaid beneficiaries who enrolled in a parent prospective cohort study and had a diagnosis of hypertension based on their Medicaid claims during a 24-month period before study enrollment. We calculated the proportion of days covered by at least one antihypertensive medication during the first 12 months after study enrollment using the prescription claims data. We measured numerous SDH at the time of study enrollment and we categorized our hypertension cohort into 4 social risk groups based on their response profiles to the SDH variables. We compared the mean proportion of days covered by the different levels of the SDH factors. We modeled the odds of being covered by an antihypertensive medication daily throughout the follow-up period by social risk group, adjusted for age, sex, and disease severity using a generalized linear model. Results: The nonrandom sample was predominately Black (93%), female (62%) and had completed high school (77%). The mean proportion of days covered varied significantly by different SDH, such as food insecurity (49%–56%), length of time living at present place (47%–57%), smoking status (50%–56%), etc. Social risk group was a significant predictor of medication adherence. Participants in the 2 groups with the most social risks were 36% (adjusted odds ratio=0.64 [95% CI, 0.53–0.78]) and 20% (adjusted odds ratio=0.80 [95% CI, 0.70–0.93]) less adherent to their hypertension therapy compared with participants in the group with the fewest social risks. Conclusions: Social risks are associated with lower antihypertensive medication adherence in the Medicaid population.

12 June 2018 in Clinical Toxicology
Verified
Journal Article
Closed access
MWMarcee E. Wilder
Marcee E. Wilder
LRLynne D. Richardson
Lynne D. Richardson
RHRobert S. Hoffman
Robert S. Hoffman
GWGary Winkel
Gary Winkel
AMAlex F. Manini
Alex F. Manini
Objectives: Racial and ethnic disparities in the United States continue to exist in many disciplines of medicine, extending to care in the Emergency Department (ED). We sought to examine the relationship between patient race/ethnicity and use of either antidotal therapy or gastrointestinal decontamination for individuals presenting to the ED for acute drug overdose. Methods: We completed a secondary analysis of a prospective cohort of patients with suspected acute overdose presenting to two urban tertiary care hospitals between 2009 and 2014. Race was self-identified during ED registration. Antidote administration (primary outcome) and gastrointestinal decontamination (secondary outcome) were reviewed and verified via agreement between two board certified medical toxicologists. Associations between race and outcomes were analyzed using a logistic regression model. Results: We reviewed 3252 ED patients with acute overdose. Overall, 542 people were treated with an antidote and 234 cases were treated with activated charcoal, either single or multiple dose. Compared to Whites, Blacks and Hispanics were significantly less likely to receive any antidote. The analysis was underpowered to detect racial disparities in the administration of activated charcoal. Conclusions: Blacks and Hispanics are significantly less likely to receive any antidote when presenting to the ED for acute drug overdose. Further studies are needed to determine national prevalence of this apparent disparity in care and to fully characterize how race plays a role in management of acute overdose.

17 May 2020 in Academic Emergency Medicine
Verified
Journal Article
Open access
PDF file
JBJanice Blanchard
Janice Blanchard
THTenagne Haile-Mariam
Tenagne Haile-Mariam
NPNatasha N Powell
Natasha N Powell
ATAisha Terry
Aisha Terry
MFMalika Fair
Malika Fair
YHYolanda Haywood
Yolanda Haywood
We are colleagues and friends working together in busy emergency departments in Washington DC. As Black physicians working in urban America, we do not find the recent deluge of news reports chronicling the disproportionate effect that the coronavirus disease (COVID‐19) pandemic is having on the disenfranchised and minority populations in our country shocking. We have long been witness to and are in a constant state of alarm over the legal, medical, educational, social and economic inequities faced by the most vulnerable residents of this country.

17 June 2025 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
ADAleksandra Degtyar
Aleksandra Degtyar
MWMarceé E. Wilder
Marceé E. Wilder
LRLynne D. Richardson
Lynne D. Richardson
KSKimberly T. Souffront
Kimberly T. Souffront

24 September 2024 in Journal of Emergency Nursing
Verified
Journal Article
Closed access
KSKimberly Souffront
Kimberly Souffront
CSClaire Shubeck
Claire Shubeck
BNBret P. Nelson
Bret P. Nelson
MLMegan Lukas
Megan Lukas
LGLauren Gordon
Lauren Gordon
BCBernice Coleman
Bernice Coleman